Pipeline

NEWS

10 Oct 2018

CONARIS out-licenses colonoscopy technology

[more]

Forschung_und_Entwicklung_2016_web_en
180711 Pipeline

 

FE 999301

Drug candidate: IL-6 trans-signalling inhibitor (out-licensed to Ferring Pharmaceuticals)

CR12/01

Drug candidate: gut microbiota modulator (small molecule)

 

CR12/02

Drug candidate: gut microbiota modulator (small molecule)

CR13/01

Drug candidate: intestinal microenvironment transfer / fecal filtrate transfer (sold in 2017)

CR15/01

Diagnostic product candidate for colonoscopy (out-licensed in 2018)

Last update: 02 November, 2018

 

Deutsch

 

 

© 2002-2018 Conaris Research Institute AG  I  Impressum I Data Privacy Statement I Disclaimer I Terms of Business